Impact of Molecular Pathological And Clinical features for adjuvant Treatment selection in Endometrial cancer: Multicentric Asian Registry (IMPACT-Endo-Asia)

The treatment practices for endometrialcancer have significantly changed over the last two decades. Nowadays, inaddition to standard pathology, additional tests are performed to understand  the behaviour of tumour so that personalizedtreatment can be advised for every patient. This approach ensures that patientswith good cancer cell features receive minimum essential radiotherapy or surgery treatment with fewer side effects,while those with poor cell features undergo more aggressive treatment to improvetheir chances of survival. However, this approach is not widely adoptedin Asian countries. To address this, we are launching a project to gather datafrom various hospitals across Asia. The project aims to understand howdifferent cancer cell factors impact treatment decisions and identify betterways to select additional treatment plans based on a patient’s cancer cellfeatures. The project will gather data from around 300 patients who were evaluated or treated between January 2021 andDecember 2023. It will run for two years to improve our understanding and gaininsights into the best ways to treat endometrial cancer.